Funding Flows for Stem Cell Research

The American Red Cross, the first organization to receive a human embryonic stem cell (HESC) research grant in from the US government, surprised the scientific community by rejecting the money, fanning the international policy debate over the use of these cells. Citing a change in research policy, the organization, which manages most of the US blood supply, turned down a $50,000 (US) grant to expand its research of mouse umbilical cells into the controversial HESCs. Nevertheless, the National I

Written byTed Agres
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Nevertheless, the National Institutes of Health joins granting agencies in Europe and Canada in evaluating further applications for government HESC funding. NIH administrators plan to award at least $4 million in supplemental and training grants and infrastructure awards in 2002. In addition, NIH institutes and centers will hand out an unspecified amount of funding for new research projects, according to Wendy Baldwin, deputy director for extramural research. "We have eight or nine applications in the review cycle now," she says. "They will be reviewed for scientific merit and then go to the summer round of council reviews. What we spend depends on the requests we receive."

Some European governments have reacted cautiously to the controversy. In Germany, the government plans to fund research only with cells harvested from embryos cloned in other countries and, as a practical matter, will likely fund work on cells listed on the NIH registry, according ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies